How many studies have been conducted on Desvenlafaxine Succinate?

BiohacksAI has indexed 90 PubMed studies on Desvenlafaxine Succinate, including 32 randomized controlled trials (RCTs). 79% of studies involve human subjects.

What are the main research areas for Desvenlafaxine Succinate?

The primary research domains for Desvenlafaxine Succinate are 🌤️ Mood & Depression, 🧬 Hormones, 🧠 Focus & Attention. This is based on analysis of 90 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Desvenlafaxine Succinate

A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.

90+ PubMed studies analyzed · 32 RCTs · Evidence Score: 59.5

Research Domains

Desvenlafaxine Succinate has been studied across 14 research domains including 🌤️ Mood & Depression, 🧬 Hormones, 🧠 Focus & Attention, 🫘 Kidney, 🫁 Liver & Detox. The primary research focus is 🌤️ Mood & Depression with 23% of studies addressing this area.

Loading evidence profile...

This evidence profile for Desvenlafaxine Succinate is generated deterministically from 90 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.